All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @vitofitnesslife on TikTok · 76s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @vitofitnesslife's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00So guys someone commented I wanted my post talking about left in trickular hypertrophy and
  2. 0:06I was explaining in that video how
  3. 0:08TRT low TRT dosages is under 150 per week anything higher than that you will probably get the hypertrophy
  4. 0:16And somebody commented on that video that he was on 200 milligrams and after one year
  5. 0:21He got mild
  6. 0:24Hypertrophy of the heart so I wasn't lying the study show it and he's an example
  7. 0:31Now it's mild so it is reversible like explaining that response video
  8. 0:35I just made it to him as long as you do cardio four times a week
  9. 0:39H4 which is doing 140
  10. 0:43Heart rate only for half hour which is probably like a very light jog if you do like
  11. 0:50Intense cardio running at like a six or higher fiber higher even you could even make it worse
  12. 0:55So you got to do a very light jog four times a week
  13. 0:59and also of course keep testosterone level your dosages on their 150 per week and
  14. 1:06Preferably take telemas aren't it's not only blood pressure med it's a blood pressure med but it's proven to reverse
  15. 1:12LbH so very important

TRT and left ventricular hypertrophy: what the evidence shows

Vito

TikTok creator

14.8K viewsWatch on TikTok

Quick answer

Left ventricular hypertrophy associated with exogenous testosterone use is a real and documented phenomenon, driven by supraphysiologic androgen levels, elevated hematocrit, and secondary hypertension rather than a fixed weekly dose threshold. Telmisartan, an angiotensin II receptor blocker, has published evidence supporting LVH regression and is used clinically under physician supervision, not as an over-the-counter adjunct to self-managed TRT. Patients on testosterone therapy concerned about cardiac remodeling should pursue echocardiographic evaluation and cardiovascular monitoring through a licensed provider.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 4 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For TRT and left ventricular hypertrophy: what the evidence shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

TRT and left ventricular hypertrophy: what the evidence shows is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "TRT and left ventricular hypertrophy: what the evidence shows" from Vito. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Left ventricular hypertrophy associated with exogenous testosterone use is a real and documented phenomenon, driven by supraphysiologic androgen levels, elevated hematocrit, and secondary hypertension rather than a fixed weekly dose threshold.

The reason this review is not generic is the source wording and the canonical claim label "trt i m telling you but you don t want to listen testestorone tr." In this clip, the useful excerpt is: "So guys someone commented I wanted my post talking about left in trickular hypertrophy and I was explaining in that video how TRT low TRT dosages is under 150 per week anything higher than that you will probably get the hypertrophy And..." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Baggish et al.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Left ventricular hypertrophy associated with exogenous testosterone use is a real and documented phenomenon, driven by supraphysiologic androgen levels, elevated hematocrit, and secondary hypertension rather than a fixed weekly dose threshold.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Left ventricular hypertrophy associated with exogenous testosterone use is a real and documented phenomenon, driven by supraphysiologic androgen levels, elevated hematocrit, and secondary hypertension rather than a fixed weekly dose threshold. Telmisartan, an angiotensin II receptor blocker, has published evidence supporting LVH regression and is used clinically under physician supervision, not as an over-the-counter adjunct to self-managed TRT. Patients on testosterone therapy concerned about cardiac remodeling should pursue echocardiographic evaluation and cardiovascular monitoring through a licensed provider.
  • No published study establishes 150mg of testosterone per week as a validated threshold for LVH risk. Risk is determined by cumulative dose, duration, hematocrit, blood pressure, and individual cardiovascular history.
  • Baggish et al. (2016, Circulation) confirmed supraphysiologic androgen use is associated with left ventricular wall thickening and diastolic dysfunction, primarily studied in anabolic steroid users rather than clinical TRT patients.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • No published study establishes 150mg of testosterone per week as a validated threshold for LVH risk. Risk is determined by cumulative dose, duration, hematocrit, blood pressure, and individual cardiovascular history.
  • Baggish et al. (2016, Circulation) confirmed supraphysiologic androgen use is associated with left ventricular wall thickening and diastolic dysfunction, primarily studied in anabolic steroid users rather than clinical TRT patients.
  • Zone 2 aerobic exercise, roughly 60-70% of maximum heart rate, supports beneficial cardiac remodeling and is preferred over high-intensity training for individuals with pathological LVH, per established exercise cardiology research.
  • Telmisartan has clinical evidence for LVH regression (Verdecchia et al., 2011, Journal of the American College of Cardiology), but it requires a prescription and is not appropriate for unsupervised self-use alongside TRT.
  • Mild LVH is not always benign. Diastolic dysfunction can develop before symptoms appear, making echocardiographic monitoring an important part of long-term TRT management.
  • The American Urological Association recommends periodic cardiovascular assessment for men on testosterone therapy, including hematocrit and blood pressure monitoring, not self-adjusted dose thresholds.
  • A commenter's anecdote on social media does not constitute study confirmation. Individual cases can illustrate risk but cannot establish dose-response relationships.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @vitofitnesslife actually say?

The creator argues that TRT doses under 150mg per week are safe for the heart, but anything above that threshold will "probably" cause left ventricular hypertrophy (LVH). He points to a commenter who developed mild LVH on 200mg per week as validation. His prescription for reversing it: zone 2 cardio four times a week at around 140 BPM for 30 minutes, keeping doses under 150mg, and taking telmisartan, which he describes as a blood pressure medication with proven LVH-reversing effects.

He also warns that high-intensity cardio above a pace of six miles per hour could worsen LVH, and frames mild LVH as reversible if caught early. One commenter's anecdote is presented as evidence that "the studies show it." That last part deserves scrutiny.

Does the science back this up?

Partially, but the 150mg cutoff is not supported by any published threshold study. The relationship between exogenous testosterone and LVH is real and documented, but it is dose-dependent and individual, not governed by a clean weekly milligram line.

A 2016 meta-analysis by Baggish et al. in Circulation found that supraphysiologic androgen use is associated with left ventricular wall thickening and impaired diastolic function. However, this research focused heavily on anabolic steroid users, not TRT patients in clinical ranges. A 2010 study by Urhausen et al. in the International Journal of Sports Medicine noted that cardiac remodeling in androgen users correlates with cumulative dose and duration, not a single weekly number. The creator's specific 150mg cutoff appears to be self-derived, not extracted from peer-reviewed data. No major cardiology or endocrinology guideline uses that figure as a threshold.

The zone 2 cardio recommendation, however, has real support. Research on exercise-induced cardiac remodeling, including work by La Gerche et al. in the European Heart Journal (2012), confirms that low-intensity aerobic exercise promotes beneficial cardiac adaptation rather than pathological remodeling.

What did they get wrong (or right)?

The creator gets the general direction right: high doses of testosterone carry cardiac risk, zone 2 cardio is preferable to high-intensity work for LVH management, and telmisartan does have data supporting LVH regression. Those are fair points.

Where it falls apart is the precision. Framing 150mg per week as a hard safety threshold is misleading. Some individuals develop cardiac changes at lower doses due to hematocrit elevation, sleep apnea, genetic predisposition, or pre-existing hypertension. Others on higher therapeutic doses under physician supervision may show minimal remodeling. A single commenter's experience is anecdote, not confirmation that "the studies show it."

Telmisartan's LVH reversal data is legitimate. A 2011 trial published in the Journal of the American College of Cardiology by Verdecchia et al. confirmed telmisartan's superiority over other ARBs in LVH regression. But recommending a specific prescription drug by name to a general TikTok audience, without framing it as something requiring a physician's involvement, is a problem. That is not a supplement. It requires a diagnosis and a prescription.

What should you actually know?

If you are on TRT and concerned about heart health, the honest answer is that no weekly milligram number guarantees safety. Your individual cardiovascular risk profile matters far more than hitting an arbitrary threshold.

Echocardiographic monitoring is the standard of care for anyone on long-term testosterone therapy, particularly at doses above physiologic replacement levels. A 2021 consensus statement from the American Urological Association recommends periodic cardiovascular assessment for TRT patients, including hematocrit monitoring and blood pressure tracking. LVH is not just a bodybuilder problem. It is a documented risk at supraphysiologic testosterone levels, and "mild" does not always mean harmless, as diastolic dysfunction can develop before symptoms appear.

Zone 2 cardio is genuinely good advice for heart health in this population. The zone 2 principle is backed by solid physiology. But if you have been told you have LVH, that conversation needs to happen with a cardiologist, not a TikTok comment section. Telmisartan may well be appropriate, but that is a clinical decision, not a self-prescribed supplement stack.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Vito · TikTok creator

14.8K views on this video

I’m telling you but you don’t want to listen… #testestorone #trt #lvh #leftventriclehyperthropy #steroidtalk

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about no published study establishes 150mg of testosterone per week as?

No published study establishes 150mg of testosterone per week as a validated threshold for LVH risk. Risk is determined by cumulative dose, duration, hematocrit, blood pressure, and individual cardiovascular history.

What does the video say about baggish et al. (2016, circulation) confirmed supraphysiologic?

Baggish et al. (2016, Circulation) confirmed supraphysiologic androgen use is associated with left ventricular wall thickening and diastolic dysfunction, primarily studied in anabolic steroid users rather than clinical TRT patients.

What does the video say about zone 2 aerobic exercise, roughly 60-70% of maximum heart rate,?

Zone 2 aerobic exercise, roughly 60-70% of maximum heart rate, supports beneficial cardiac remodeling and is preferred over high-intensity training for individuals with pathological LVH, per established exercise cardiology research.

What does the video say about telmisartan has clinical evidence for lvh regression (verdecchia et al.,?

Telmisartan has clinical evidence for LVH regression (Verdecchia et al., 2011, Journal of the American College of Cardiology), but it requires a prescription and is not appropriate for unsupervised self-use alongside TRT.

What does the video say about mild lvh?

Mild LVH is not always benign. Diastolic dysfunction can develop before symptoms appear, making echocardiographic monitoring an important part of long-term TRT management.

What does the video say about the american urological association recommends periodic cardiovascular assessment for men?

The American Urological Association recommends periodic cardiovascular assessment for men on testosterone therapy, including hematocrit and blood pressure monitoring, not self-adjusted dose thresholds.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Not medical advice. This video was made by Vito, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.